Dupixent (dupilumab ... with an FDA decision delayed by a review of the JAK class and its potential to cause cardiovascular side effects. It's not the first JAK inhibitor to get a green ...

Multiple risk factors were associated with denials and longer wait times for biologic treatment in moderate to severe asthma, ...

Dupixent recommended after NICE rejection Meanwhile ... Regulators have started reviews of GSK's depemokimab, aiming to become the first drug for asthma that can be dosed twice a year.

The potential success in the development of the above candidates will help the company narrow its dependence on the blockbuster immunology drug Dupixent, which is marketed in collaboration with ...

The deal with startup Dren Bio hands Sanofi a so-called myeloid cell engager that would compete with an array of programs ...

“Aunt Jennifer’s Tigers,” by Adrienne Rich, is a blazing portrait of an artist and her work. Our critic A.O. Scott admires its craft — and its wildness. By A.O. Scott Hisham Matar won ...

Join former prosecutor Andy McCarthy as he delves into the legal ins and outs of the latest Washington dramas with National Review editor in chief Rich Lowry. Capital Record – your weekly ...

Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for ...

Best suv in this range with luxury and we recommend to buy this suv in such a good Price Features an ...

According to a 2024 research review, pro-inflammatory cytokines (pro-inflammatory molecules from eczema) can break through the blood-brain barrier and disrupt neurotransmitters (brain chemicals ...

How do I know I can trust these reviews about Renewal by Andersen? How do I know I can trust these reviews about Renewal by Andersen? 4,628,077 reviews on ConsumerAffairs are verified. We require ...